Streetbeat News

Price Targets

NET

Baird analyst Shrenik Kothari maintains an Outperform rating on Cloudflare (NYSE:NET) and raises the price target from $59 to $64.

Portfolio Pulse from richadhand@benzinga.com

June 28, 2023 | 2:18 pm

AVAV

Baird analyst Peter Arment has reiterated a Neutral rating on AeroVironment (NASDAQ:AVAV) and maintained a $95 price target.

Portfolio Pulse from richadhand@benzinga.com

June 28, 2023 | 2:11 pm

ZBH

Baird analyst Jeff Johnson has reiterated an Outperform rating on Zimmer Biomet Holdings (NYSE:ZBH) and maintained a price target of $172.

Portfolio Pulse from richadhand@benzinga.com

June 28, 2023 | 2:09 pm

REGN

Baird analyst Brian Skorney has maintained a Neutral rating on Regeneron Pharmaceuticals (NASDAQ:REGN) and lowered the price target from $800 to $760.

Portfolio Pulse from richadhand@benzinga.com

June 28, 2023 | 2:08 pm

CARM

Baird analyst Jack Allen has reiterated an Outperform rating on CARISMA Therapeutics (NASDAQ:CARM) and maintained a $10 price target.

Portfolio Pulse from richadhand@benzinga.com

June 28, 2023 | 2:07 pm

XPOF

Baird analyst Jonathan Komp maintains a Neutral rating on Xponential Fitness (NYSE:XPOF) and lowers the price target from $36 to $23.

Portfolio Pulse from richadhand@benzinga.com

June 28, 2023 | 2:06 pm

AHCO

Baird analyst Eric Coldwell has reiterated his 'Outperform' rating on AdaptHealth (NASDAQ:AHCO) and maintained a price target of $20.

Portfolio Pulse from richadhand@benzinga.com

June 28, 2023 | 2:04 pm

LPX

Truist Securities has upgraded Louisiana-Pacific's stock from Hold to Buy and increased its price target from $49 to $82. This has resulted in Louisiana-Pacific shares trading higher.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 2:03 pm

SQSP

B. Riley Securities has initiated coverage on Squarespace with a Buy rating and a price target of $40. This has led to an increase in the trading of Squarespace shares.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 1:47 pm

TGAN

B. Riley Securities analyst Craig Ellis has maintained a Neutral rating on Transphorm (NASDAQ:TGAN) and lowered the price target from $5.5 to $4.5.

Portfolio Pulse from richadhand@benzinga.com

June 28, 2023 | 1:46 pm